Skip to Content

LL 35 (EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg)

Generic Name: guaifenesin/hydrocodone

Pill with imprint LL 35 is White, Capsule-shape and has been identified as EndaCof Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg. It is supplied by Larken Laboratories, Inc..

EndaCof-Tab is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. EndaCof-Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for LL 35

EndaCof Tab

Generic Name
guaifenesin/hydrocodone
Imprint
LL 35
Strength
guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Larken Laboratories, Inc.
National Drug Code (NDC)
54868-5492

Get help with Imprint Code FAQs.

Related Images for "LL 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.